Computational biology study found two fundamental mechanisms involved in the cell play important roles and may help better control cells used in regenerative medicine applications
$430,000 investment to study if a type of immune cell could be the key to transplanting insulin-producing cells for diabetes treatment
"The infiltration of new technologies into mainstream scientific research is incredible. I mean, synthetic biology, AI, machine learning, resolution at the single cell level. I love interdisciplinary science and I love technology."
Over the past two weeks, PRiME partnered with Medicine by Design to host a virtual Cell and Gene Therapies Innovation Showcase, highlighting novel strategies and enabling technologies poised to advance the field.
Three investigators join a cohort of 15 faculty members who have been supported by Medicine by Design’s New Investigators program.
What if manufacturing proteins was a simple as brewing a cup of coffee?
Research team looks to blood for answers on why aging can cause inflammation and disease
"It’s been amazing to witness the marriage of biological engineering and cell and molecular biology, which will generate regenerative medicine’s next wave of discoveries and therapeutics."
Thanks to this team’s effective storytelling, sound science and clear pathway to translation, HDAX was chosen by the judges to receive research funding.
The doctoral exchange is part of a larger partnership called the Leukemia Consortium, which seeks to generate a comprehensive data set pertaining to human blood stem cells and the leukemia that originates from them.
This “revolutionizing biology” offers the promise of new treatments for diseases and conditions including inflammatory bowel disease and autism spectrum disorder.
Researchers say the findings lay groundwork that could lead to methods for expanding stem cell numbers from donated cord blood biobanks to improve availability for people with leukemia.
Parliamentary Secretary to the Minister of Innovation, Science and Industry (Innovation and Industry) lauds Medicine by Design’s new research program
Teams were selected because of the strength of their concepts, which all have potential to make a positive contribution to the regenerative medicine-related ecosystem.
"My research is at the intersection of biology and physics. It’s really the fundamental questions that drive me. I hope that one day my work on these fundamental questions might lead others to develop new therapies."
